*The following content is generated by AI and is for reference only.
Overview
Linzagolix choline is a selective gonadotropin-releasing hormone (GnRH) receptor antagonist developed as an Active Pharmaceutical Ingredient (API). The compound features a specific choline salt form to enhance solubility and bioavailability. Its molecular formula is C26H34N4O5S with CAS number 1786905-64-3.
Application
- Gynecology: Management of moderate-to-severe pain associated with endometriosis.
- Oncology: Adjunct therapy for estrogen-dependent tumors requiring GnRH blockade.
- Research: Preclinical studies on reproductive hormonal regulation mechanisms.
Precautions
Strict adherence to clinical dosing protocols is required to avoid adverse hepatic effects. Store in a cool, dry place below 25°C protected from light. Handling requires PPE including gloves and goggles to prevent skin or eye irritation during manufacturing processes.